Apoptosis and its relationship with cell proliferation, p53, Waf1p21, bcl-2 and c-myc in esophageal carcinogenesis studied with a high-risk population in northern China

World Journal of Gastroenterology

Volumn 4, Issue 1-6, 1998, Pages 287-293

  Wang, Li Dong ^a   Zhou, Qi ^a   Wei, Jun Ping ^a   Yang, Wan Cai ^a   Xin, Zhao ^a   Wang, Li Xia ^a   Zou, Jian Xiang ^a   Gao, Shan Shan ^a   Li, Yong Xin ^a   Yang, C S ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Apoptosis; bcl 2 gene; c myc gene; Esophageal neoplasms; p53 gene; Precancerous lesions; Waf1 p21 gene

Indexed keywords

EID: 0000586543     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v4.i4.287     Document Type: Article

References (37)

1. Yang CS. Research on esophageal cancer in China; a review. Cancer Res, 1980; 40(7):2633-2644
2. Lu JB, Yang WX, Zu SK, Zchang QL, Sun XB, Lu WQ et al. Cancer mortality and mortality trends in Henan, China, 1974-1985. Cancer Detect Prev, 1988;13 (2):167-173
3. Correa P. Precursors of gastric and esophageal cancer. Cancer (Phil.), 1982;50 (11):2554-2565
4. Munoz N, Crespi M, Grassi A, Wang GQ, Shen Q, Li ZC. Precursor lesions of oesophageal cancer in high-risk population in Iran and China. Lancet, 1982;1 (5):876-879
5. Qiu SL, Yang GR. Precursor lesions of esophageal cancer in high-risk populations in Henan Province, China. Cancer (Phila.), 1988;62(3):551-557
6. Wang LD, Lipkin M, Qiu SL, Yang GR, Yang CS, Newmark HL. Labeling index and labeling distribution of cells in esophageal epithelium of individuals at increased risk for esophageal cancer in Huixian, China. Cancer Res, 1990;50(9): 2651-2653
7. Kerr JFR, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer therapy. Cancer, 1994;73(8):2013-2026
8. Kastan MB, Canman CE, Leonard CJ. p53, cell cycle control and apoptosis: implications for cancer. Cancer Metas Rev, 1995;14(1)3-15
9. Uhlmanu EJ, D'sa-Eipper C, Subramanian T, Wagner AJ, Hay N, Chinnadurai G. Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. Cancer Res, 1996;56 (10):2506-2509
10. Korsmeyer SJ. Bcl-2 initiates a new category of oncogens: regulators of cell death. Blood, 1992;80(5):879-886
11. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol, 1994; 124(1):1-6
12. Vaux DL, Cory S, Adams JM. bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond), 1988;335(3): 440-442
13. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Scie USA, 1992;89 (16):7491-7495
14. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res, 1991;51 (23):6304-6311
15. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science (Washington DC), 1994;266(13):1821-1828
16. Shimamura A, Fisher DE. p53 in life and death. Clinical Cancer Res, 1996;2 (3):435-440
17. Sheikh MS, Rochefort H, Garcia M. Overexpression of p21 Waf1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene, 1995;11(9):1899-1905
18. Wang LD, Hong JY, Qiu SL, Gao HK, Yang CS. Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res, 1993;53(8):1783-1787
19. Wang LD, Shi ST, Zhou Q, Goldstein S, Hong JY, Shao P et al. Changes in p53 and cyctin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int J Cancer, 1994; 59 (4): 514-519
20. Gao HK, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res, 1994; 54 (16): 4342-4346
21. Wang LD, Zhou Q, Hong JY, Qiu SL, Yang CS. p53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China. Cancer, 1996;77(7):1244-1249
22. Shi ST, Feng B, Yang GY, Wang LD, Yang CS. Immunohistosclective sequencing (IHSS) of p53 tumor suppressor gene in human oesophageal precancerous lesions. Carcinogenesis, 1996;17(1):101-106
23. Wang LD, Qiu SL, Yang GR, Lipkin M, Newmark HL, Yang CS. A randomized double-blind intervention study on the effect of calcium supplementation on esophageal precancerous lesions in a high risk population in China. Cancer Epidemiol Biomarkers Prev, 1993;2(1):71-78
24. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer, 1972;26(2):239-257
25. Meyn RE, Stephens LC, Mason KA, Medina D. Radiation-induced apoptosis in normal and pre-neoplastic mammary glands in vivo: significance of gland differentiation and p53 status. Int J Cancer, 1996;65(3):466-472
26. Ei-Labban NG, Osorio-Herrera E. Apoptotic bodies and abnormally dividing epithelial cells in squamous cell carcinoma. Histopathology, 1986; 10(5): 921-931
27. Tormanen U, Eerola AK, Rainio P, Vahakangas K, Soini Y, Sormunen R et al. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res, 1995;55(23):5595-5602
28. Ohbu M, Saegusa M, Okayasu I. Apoptosis and cellular proliferation in oesophageal squamous cell carcinomas: differences between keratinizing and nonkeratinizing types. Virchows Arch, 1995;427(3):271-276
29. Tatebe S, Ishida M, Kasagi N, Tsujitani S, Kaibara N, ito H. Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: analysis by terminal-deoxynucleotide-transferase-mediated dUTP-biotin nick end labeling. Int J Cancer, 1996;65(2):173-177
30. Mundle SD, Gao XZ, Khan S, Gregory SA, Preisler, HD, Raza A. Two in situ labeling techniques reveal different patterns of DNA fragmentation during spontaneous apoptosis in vivo and induced apoptosis in vitro. Anticancer Res, 1995;15(4):1895-1904
31. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res, 1995; 55(5):1811-1861
32. Staunton MJ, Gaffney EF. Tumor type is a determinant of susceptibility to apoptosis. Am J Clin Pathol, 1995;103(3):300-307
33. Marx J. Cell death studies yield cancer clues. Science, 1993;259(5):760-761
34. Lane DP. p53, guardian of the genome. Nature, 1992;358(6381):15-16
35. Bartek J, Bartkova J, Vojtesck B. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene, 1991;6 (9):1699-1703
36. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-mys is inhibited by bcl-2. Nature, 1992;359(6395):552-554
37. Barbareschi M, Caffo O, Doglioni C, Fina P, Marchetti A, Buttitta F et al. P21Waf1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse free survival. Br J Cancer, 1996;74(2):208-215